Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva maintenance after platinum-based chemotherapy in advanced non-small cell lung cancer
2005-002241-39Phase 3Completed
- Sponsor
- Roche
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in non-small cell lung cancer (NSCLC) comparing Tarceva maintenance with Placebo maintenance (2 arms). Primary endpoint: Progression-free survival. Started Sep 2005; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2005-002241-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002241-39.